pg/kg) on the von Bezold-Jarisch reflex lasted for 3-6 hr, whereas ondansetron (700 pg/kg, p.o.) an tagonized 5-HT3 receptors for only 1 hr. In isolated guinea pig colon, the inhibitory effect of YM-com pounds on 5-HT-induced contraction persisted significantly longer than those of ondansetron and granisetron after washout of the bath containing compounds. These results suggest that YM-compounds are highly potent 5-HT3-receptor antagonists. Furthermore, non-competitive 5-HT3-receptor antagonism of YM-compounds against the von Bezold-Jarisch reflex at higher doses may be reflected in their slow dissocia tion from the 5-HT3 receptor, and that of granisetron may be reflected in its slow metabolism in anesthetiz ed rats.
Higher doses of these compounds inhibited 5-HT-induced bradycardia with a reduced maximal response. In contrast, ondansetron displaced the 5-HT dose-response curve to the right without affecting the maximal response. Judged by the apparent DR2 values, YM060, YM114, YM-26103-2 and YM 26308-2 were approximately 13, 13, 50 and 79 times more potent than ondansetron, respectively, whereas granisetron was equipotent to ondansetron. Single i.v. doses of YM060 and granisetron inhibited 5-HT induced bradycardia significantly longer than ondansetron. Moreover, inhibitory effects of p.o. doses of YM060 (3 pg/kg), YM 114 (80 pg/kg), YM-26103-2 (12 pg/kg), YM-26308-2 (5 pg/kg) and granisetron (250 pg/kg) on the von Bezold-Jarisch reflex lasted for 3-6 hr, whereas ondansetron (700 pg/kg, p.o.) an tagonized 5-HT3 receptors for only 1 hr. In isolated guinea pig colon, the inhibitory effect of YM-com pounds on 5-HT-induced contraction persisted significantly longer than those of ondansetron and granisetron after washout of the bath containing compounds. These results suggest that YM-compounds are highly potent 5-HT3-receptor antagonists. Furthermore, non-competitive 5-HT3-receptor antagonism of YM-compounds against the von Bezold-Jarisch reflex at higher doses may be reflected in their slow dissocia tion from the 5-HT3 receptor, and that of granisetron may be reflected in its slow metabolism in anesthetiz ed rats.
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von Bezold-Jarisch reflex Serotonin (5-HT) receptors have been classified into at least four subtypes: 5-HT,, 5-HT2, 5-HT3 and 5-HT4 (1). Among these, research into 5-HT3 receptors, which are lo cated in both the central and peripheral nervous systems (2-4), has advanced remarkably. This receptor has been implicated in anxiety (5, 6) , schizophrenia (7), stress induced gastrointestinal disorders (8) and vomiting re sponses to cancer chemotherapeutic agents (9, 10) .
A number of 5-HT3-receptor antagonists have been de veloped in the last decade: among these, ondansetron and granisetron are already available for clinical use. Recent reports (11, 12) have shown a novel 4,5,6,7-tetrahydro benzimidazole derivative, YM060, to be a more potent and selective 5-HT3-receptor antagonist than either of these two agents.
The mode of 5-HT3-receptor antagonism of these com pounds has been investigated in vitro using the ileum and colon of guinea pigs (11, 13, 14) , vagus nerve of rats and rabbits (13) (14) (15) and the nodose ganglion of rabbits (16) . Investigation of their mode of action in in vivo systems, however, has not been performed. In the present study, we assessed the mode of the 5-HT3-receptor antagonism of novel 4,5,6,7-tetrahydrobenzimidazole derivatives ( Fig. 1 ) by measuring their ability to block 5-HT-induced bradycardia (the von Bezold-Jarisch reflex) in anesthe tized rats, and the results were compared with those of on dansetron and granisetron. Moreover, we evaluated the dissociation of these derivatives from the 5-HT3 receptor using isolated guinea pig colon. 
MATERIALS AND METHODS
The von Bezold-Jarisch reflex in anesthetized rats Male Wistar rats (250-350 g) were used. Food and water were available ad libitum. In the oral administra tion tests, they were fasted for 24 hr before the experi ments, but were allowed free access to water. The rats were anesthetized with urethane (1.25 g/kg, i.p.). A poly ethylene tube was inserted into the trachea for artificial ventilation (60 respirations per min; tidal volume, 3.0 ml). The left common carotid artery was cannulated with a polyethylene catheter connected to a pressure trans ducer (MPU-0.5; Nihon Kohden, Tokyo). The pressure signal was amplified with a carrier amplifier (AP-621G, Nihon Kohden), and the heart rate was measured with a cardiotachometer (AT-600G, Nihon Kohden) triggered by the blood pressure pulse. The blood pressure and heart rate were monitored continuously and recorded (RMP 6008, Nihon Kohden). For intravenous drug administra tion, a catheter was inserted into the left femoral vein.
A dose-response curve for 5-HT-induced bradycardia was constructed by increasing doses of 5-HT (5 -1000 ug/kg, i.v.) every 15 min. Because preliminary experi ments showed the dose-response curve for 5-HT to be reproducible in the same animal (Fig. 2) , test compounds were injected i.v. 10 min before constructing the second dose-response curve for 5-HT to investigate the mode of the 5-HT3-receptor antagonism. Only one dose of test compound was examined per animal. Apparent DR2 values for the test compounds were calculated to estimate their 5-HT3-receptor blocking activity.
In another series of experiments, the duration of 5-HT3 receptor antagonism after i.v. administration of test compounds was evaluated. A submaximal dose of 5-HT (30 pg/kg, i.v.) was used to examine the inhibitory effect of test compounds. After the control response to 5-HT was obtained, the inhibitory effects of single i.v. doses of YM060 (0.3 pg/kg), granisetron (10 pg/kg) and ondanse tron (30 pg/kg) on the 5-HT-induced bradycardia was measured at 15 to 30-min intervals after dosing.
The duration of 5-HT3-receptor antagonism after p.o. administration of test compounds was evaluated. Thirty minutes after dosing, the rats were anesthetized and pre pared surgically as described above. The inhibitory effects of single p.o. doses (approximating the ID80 value at 1 hr after dosing) of test compounds on the 5-HT (30 pg/kg, i.v.)-induced von Bezold-Jarisch reflex were measured at 1 hr intervals after dosing. Methylcellulose solution (MC, 0.5% w/v) was administered to the vehicle control group.
Evaluation of the antagonist dissociation in the guinea pig colon
Male Hartley guinea pigs (570 850 g) were used. Food and water were available ad libitum. The guinea pigs were killed by cervical dislocation. The distal portion of the colon (approximately 2-cm-long) was used. Tissues were mounted in organ baths containing 10 ml Krebs-bicar bonate solution maintained at 37C and aerated with a mixture of 95% 02 and 5% CO2. The composition of Krebs-bicarbonate solution was: 118.4 mM NaCI, 4.7 mM KCI, 1.2 mM MgSO4i 2.5 mM CaC12, 11.1 mM dex trose, 25.0 mM NaHCO3 and 1.2 mM KH2PO4. Tissues were attached to isometric force-displacement trans ducers (SB-1T, Nihon Kohden) connected to a recorder (MC 6621; Graphtec, Tokyo) through carrier amplifiers (AP-621G, Nihon Kohden). Each tissue was placed under optimum resting force and allowed to equilibrate for ap proximately 30 min before exposure to test compounds. Isometric contraction under a loading tension of 1 g was recorded.
In preliminary experiments, 5-HT (10-7-3 x 10-'M)
produced concentration-dependent contraction in the guinea pig colon (data not shown). A submaximal con centration of 5-HT (10-5 M) was used to evaluate the inhibitory effects of test compounds. After the control responses to 5-HT were obtained, tissues were incubated with high concentrations (30 times the IC50 value) of test compounds for 15 min. After washout of the bath con taining test compounds, the 5-HT-induced contraction was measured every 15 min to determine the dissociation of test compounds from the 5-HT3 receptor in the guinea pig colon.
Statistical analyses
All values are expressed as the means --' S. E. M. or as the means with 95% confidence limits. Probit analysis was used to obtain the ID50 and ID80 values. The dose-ratio was obtained from the ratio of ED50 values for 5-HT in the presence and absence of an antagonist. Apparent DR2 values (doses of test compounds produced a dose-ratio of 2 for 5-HT) and slopes of the curves were calculated (17) . Statistical significance of values for the duration of action after i.v. dosing and washout was determined by analysis of variance at each time, and differences between treat ment groups were compared by the Sheffe-S method, Mann-Whitney U-test and Newman-Keuls multiple range test. Student's t-test was used to evaluate the duration of action after p.o. dosing between the test compound and control groups. Probabilities of < 5 % (P < 0.05) were con sidered significant.
,7-tetra hydro-1 H-benzimidazole hydrochloride), ondansetron and granisetron were prepared by Yamanouchi Phar maceutical Co., Ltd. 5-HT creatinine sulfate was pur chased from E. Merck (Darmstadt, FRG). All drug doses are expressed as the free base. Drugs were dissolved in physiological saline for i.v. administration and were sus pended in 0.5% MC solution for p.o. administration. 
RESULTS

Bradycardic response to 5-HT
The basal heart rate in anesthetized rats was 400.3±36.6 beats/min (n=4). Bolus i.v. injection of 5 HT (5 80 pg/kg) evoked a dose-dependent and transient bradycardia. The second series of 5-HT injections in each rat produced almost the same bradycardic responses as the first, indicating the dose-response curve for 5-HT to be reproducible (Fig. 2) . (Fig. 4) . Ondansetron, unlike the YM-compounds and granise tron, produced parallel shifts to the right of the 5-HT curve with the same maximal response up to 100 pg/kg, i.v. (Fig. 5) .
5-HT3-receptor blocking activities of the test drugs were evaluated using apparent DR2 values, calculated us ing the dose-ratio obtained from the parallel-shifted dose response curves. The apparent DR2 values are listed in Table 1 . Judged by these values, YM060, YM 114, YM 26103-2 and YM-26308-2 were approximately 13, 13, 50 and 79 times more potent than ondansetron, respectively, whereas granisetron and ondansetron were equipotent. 
Duration of action after i. v. administration in anesthe tized rats
To evaluate the duration of action of YM060, grani setron and ondansetron, their inhibitory effect on 5-HT (30 tcg/kg, i.v.)-induced bradycardia was examined in anesthetized rats after higher doses of YM060 (0.3 tag/kg, i.v.), granisetron (10 tcg/kg, i.v.) and ondanse tron (30 pg/kg, i.v.) were injected. After i.v. injection, YM060 significantly inhibited the von Bezold-Jarisch reflex for a longer period than ondansetron, whereas the dura tion of action of granisetron was as long as that of YM060 (Fig. 6 ). and 83.0±4.701o, respectively, immediately after 15-min incubation. 5-HT3-receptor blocking activity of all YM compounds significantly persisted longer than that of ondansetron and granisetron after washout of the bath containing the compounds (Fig. 8) . 
DISCUSSION
In the present study, we investigated the mode of the 5 HT3-receptor antagonism of YM060, YM 114, YM-26103 2, YM-26308-2, granisetron and ondansetron on the von Bezold-Jarisch reflex in anesthetized rats. All YM-com pounds have an asymmetric center (Fig. 1) , resulting in R and S-forms. As 5-HT3 receptors in the isolated guinea pig colon have a stereochemical preference for the R form of YM-compounds (11, 18), we used only the R forms of these compounds in the present system. Like YM060, the other YM-compounds have the in dolyl or indolizinyl moiety as the aromatic component. Although the position of the nitrogen atom varies among these moieties, their 5-HT3-receptor blocking activities are maintained. Based on the apparent DR2 values, the rank order of potency was YM-26308-2>YM-26103 2 > YM060= YM 114 > granisetron > ondansetron.
Lower doses of all compounds tested caused a parallel displacement of the 5-HT dose-response curve to the right, consistent with simple competitive antagonist be havior. At higher doses, ondansetron still produced a parallel shift to the right without affecting the maximal responses to 5-HT, whereas the YM-compounds and granisetron reduced the maximal responses to 5-HT. Three possibilities may explain these differences in the mode of action between YM-compounds or granisetron and ondansetron. First, the duration of the 5-HT3-recep tor blocking action of YM-compounds and granisetron, unlike that of ondansetron, may be quite long due to their slow metabolism or dissociation from the 5-HT3 receptor.
In the present study, the dissociation of all YM-com pounds from 5-HT3 receptors in the isolated guinea pig colon was significantly slower than that of ondansetron. Furthermore, the 5-HT3-receptor blocking activitiy of i.v. or p.o. doses of YM060 was longer than that of ondan setron in anesthetized rats. Taken together, long-acting
properties of YM-compounds may be reflected in their slow dissociation from 5-HT3 receptors. On the other hand, the dissociation of granisetron from 5-HT3 recep tors in the guinea pig colon was as fast as that of ondanse tron, whereas i.v. or p.o. doses of granisetron inhibited 5 HT-induced bradycardia significantly longer than ondan setron in anesthetized rats. The long-acting property of granisetron, unlike that of YM-compounds, may be reflected in its slow metabolism in anesthetized rats. Ohen et al. (19) also reported that the duration of action of granisetron was longer than that of ondansetron after i.v. injection, and it was consistent with our observation. Secondly, these 5-HT3-receptor antagonists may have non-specific antagonistic activities at other receptors. However, this possibility is unlikely because 5-HT-in duced transient bradycardia is mediated only through 5 HT3 receptors, which are located on afferent vagus nerves, and neither ketanserin, a 5-HT2-receptor an tagonist (our observation, data not shown), nor methyser gide, a 5-HT, and 5-HT2-receptor antagonist (20) , affect ed the 5-HT-evoked bradycardia. Furthermore, previous reports have shown that neither YM-compounds (includ ing YM060) nor granisetron acts on other amine receptors (11, 18) , and they have no local anesthetic effect at the doses used in the present in vivo study (data not shown). Taken together, YM-compounds and granisetron are sug gested to be highly selective 5-HT3-receptor antagonists. Finally, the pseudo-non-competitive antagonism of the high affinity antagonist may be observed against the par tial agonist-induced response, although its mode of recep tor antagonism is a competitive against the full agonist. In the present in vivo study, however, 5-HT was regarded as a full agonist for 5-HT3 receptors. Moreover, the 5 HT3-receptor blocking potency of granisetron was equipo tent to that of ondansetron. These results suggest that the last possibility can not explain the differences in the mode of the 5-HT3-receptor antagonism between YM-com pounds or granisetron and ondansetron in anesthetized rats.
In isolated guinea pig ileum (14, 21) and colon (11, 18) , YM-compounds, granisetron and ondansetron behave as competitive 5-HT3-receptor antagonists. In isolated rab bit nodose ganglion, on the other hand, antagonism by YM060, granisetron and ondansetron is non-competitive or irreversible (16) . Furthermore, in isolated rabbit vagus nerve, ondansetron behaves as a competitive 5-HT3-recep tor antagonist (14) , whereas granisetron causes non-com petitive antagonism (22) . These results offer a new dimen sion for discussion on the criteria for the classification of 5-HT3-receptor subtypes or a species difference in the 5 HT3 receptor. Since the von Bezold-Jarisch reflex was mediated through vagus nerves in anesthetized rats, the behavior of 5-HT3-receptor antagonists in the present study may be different from that in guinea pig ileum, col on and rabbit nodose ganglion. Although there are differ ences between an in vivo study and an in vitro study, the mode of action of 5-HT3-receptor antagonists in the present in vivo study (rat vagus nerve) was consistent with that in the isolated rabbit vagus nerve. On the other hand, the dissociation of granisetron from 5-HT3 receptors in the guinea pig colon was as fast as that of ondansetron. In rat vagus nerves, however, the dissociation of granisetron from 5-HT3 receptors may be slower than that of ondanse tron because of the difference in 5-HT3-receptor subtypes between rat vagus nerve and guinea pig colon. It may be reflected in the long duration of action after i.v. doses of granisetron in anesthetized rats. To make it clear, however, further investigations have to be carried out.
In conclusion, YM060, YM114, YM-26103-2, YM 26308-2 and granisetron at lower doses behaved like competitive 5-HT3-receptor antagonists against the von Bezold-Jarisch reflex in anesthetized rats, whereas at higher doses, their 5-HT3-receptor antagonism was incon sistent with a competitive interaction. In contrast, ondan setron behaved like a competitive antagonist up to 100 pg/kg, i.v. This difference may be reflected in their slow metabolism or slow dissociation from 5-HT3 receptors.
